4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0000950170-24-133373
Chief Executive Officer sold 15,000 shares at $55.10 ($826,565)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kulkarni Samarth Chief Executive Officer | 2024-12-02 | Sale 10b5-1 | −15,000 | $55.10 | $826,565 | 181,540 | D |
| Open-market sales · 15,000 sh · avg $55.10 · $826,565 | |||||||
Loading xslF345X05/ownership.xml…